About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts

Press Releases

2017 2018 2019
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

  December 2015
24 Dec  Biocon Introduces CIMIVIR-L for
 Hepatitis-C in India
Download Pdf
09 Dec  NeoBiocon Partners with Novartis to offer
 Vildagliptin for Diabetics in UAE
Download Pdf

  November 2015
13 Nov  Biocon's Nationwide 'Winning with
 Diabetes' Campaign Raises Awareness on
 Disease Prevention & Management
Download Pdf
03 Nov  Biocon is the Only Asian Company to be
 ranked in Top 20 Global Biotech Employers
 for 2015
Download Pdf

  October 2015
20 Oct  Biocon Q2FY16 Revenues up 12%; Net
 Profit up 200%; Syngene delivers 30%
Download Pdf

  September 2015
15 Sept  Biocon Inaugurates World Class Devices
 Facility & Introduces Basalog One
 Forges Ahead on 'Make in India for the
 World' Mission
Download Pdf

  July 2015
23 Jul  Biocon's Earnings Surge in Q1 FY16;
 Revenue up by 15% at Rs. 857 Crore,
 Net pofit up by 23% at Rs. 126 Crore
Download Pdf

  May 2015
07 May  Biocon-Mylan Programs Make Progress:
 PEG-G-CSF and Adalimumab enter Phase
 3 clinical trials; Patient recruitment for one
 Insulin Glargine Phase 3 study completed
Download Pdf

  April 2015
30 Apr  Biocon top line grows 15% in Q4 FY15;
 Research Services delivers 27% growth;
 FY15 Revenues at Rs. 3143 Crore, PAT at
 Rs. 497 Crore
Download Pdf
28 Apr  Biocon's CRO Arm Syngene Seeks
 Approval for IPO, Files DRHP; Offer allows  Biocon to monetize its shareholding in  Syngene
Download Pdf
09 Apr  Biocon Strengthens its Presence in Mexico;
 Receives Approval for Insulin Glargine
 through its partner PiSA Farmaceutica
Download Pdf
08 Apr  Biocon Foundation Recognized for
 Outstanding Contribution to Public Health
 by WHO - India
Download Pdf

  March 2015
05 Mar  Kiran Mazumdar-Shaw Honoured by
 Federation University Australia
Download Pdf

  Jan 2015
22 Jan  Dr Jeremy Levin Joins Biocon's Board of
Download Pdf
22 Jan  Dr Vijay Kuchroo Joins Biocon's Board of
Download Pdf
22 Jan  Biocon Q3 FY15 Revenues at Rs. 779
 Crore, PAT at Rs. 91 Crore; Research
 Services delivers 20% growth; Board
 approves listing Syngene via Offer for Sale
Download Pdf




Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved